For once, Pfiz­er's Covid pill fails in a tri­al — but on­ly af­ter seek­ing a much broad­er pop­u­la­tion

Pfiz­er’s Covid-19 pill, which has boast­ed over­whelm­ing­ly strong da­ta in pro­tect­ing cer­tain high-risk peo­ple with Covid-19 from end­ing up in the hos­pi­tal or dy­ing, now …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER